Faced with high drug prices, seniors are abandoning cancer drugs at the pharmacy

Why wouldn’t a senior get a drug that could potentially save their life? The study’s lead author says it’s the high out-of-pocket costs seniors face at the pharmacy counter.

The pressure on Medicare just keeps ramping up

Medicare is set to decide this month whether to finalize its plan to only pay for Biogen’s controversial Alzheimer’s drug, Aduhelm, when patients are enrolled in clinical trials. And advocates who oppose the idea are in the middle of a massive lobbying blitz to get them to change their minds.

Read the rest…